The market is forecast to reach $ 30.35 billion by 2021 at a Compound Annual Growth Rate (CAGR) of 15.38 %.
Proteomics is the study of protein structure and function. And at the cellular level, proteomics is, which proteins are expressed, when and where they are expressed, what their structure in both active and inactive states is, what roles they play in the life of the cell, and how they interact with other proteins and molecules.
The major drivers will continue to be the biopharmaceutical industrys pursuit of blockbuster drugs and the recent technological advances in the studies of genes and proteins. Alliances are becoming increasingly important in this field, because it is challenging for companies to find all necessary expertise to cover all activities involved in proteomics. For example, many companies working with mass spectrometry, both the manufacturers and end user labs, are collaborating with protein chip related companies. Increased demands of personalized medicines and Increased R& D in proteomics are also driving factors for the market. However, market is constrained by strict regulatory norms, reduced government and private funding for the development in proteomics field.
Protein microarray dominated the market of proteomics in Instrumentation technology accounting for nearly half of the market, followed by Spectroscopy techniques which account for approximately 35% of the market.
North America dominated the market in 2013 accounting for 40% of the market share, followed by Europe and Asia-Pacific. However, market for this region will decrease to 35% in coming years because of the lower investment from government in research and development supporting proteomics. Asia-Pacific region will be showing growth at a CAGR of 15.31% and is poised to grow because of growing research base in this region and increased pharmaceutical research including drug discovery and drug development.
In this proteomics marketis report segmented by Instrumentation technology, by services market, by applications and by geography. Instrumentation technology is further segmented into protein microarray; spectroscopy, and chromatography etc., Services market is segmented into analytical laboratory services and data analysis and maintenance. Proteomics application is segmented into drug discovery, clinical diagnosis and others. By geography market is segmented into North America, Europe and Asia-Pacific.
Major companies discussed in the report are Thermo Fisher Scientific Inc., Danaher Corporation Bio-Rad Laboratories, Inc., Affymetrix Inc., Sigma-Aldrich Corp , GE Healthcare etc.
What the report offers:
1)Market definition for Global Proteomics market with information on drivers and restraints.
2)Market Analysis involving Spectroscopy, X Ray Crystallography, Protein microarrays etc.
3)Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
4)Extensively researched competitive landscape with profiles of major companies along with their market share.
5)A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Reasons for buying this report:
1)We provide you the In-depth market segmentation by Instrumentation Technology (Spectroscopy, X Ray Crystallography, Protein microarrays), by applications (drug discovery, clinical diagnosis etc.), by geography (North America, Europe, Asia-Pacific).
2)Would be of assistance in providing a comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.
3)Wide-ranging information provided about the leading market players, major strategies adopted by them and new products launched by them.